On top of that, other research groups noticed enhanced expression of PD-L1 and PD-1 on leukemia cells after decitabine treatment [50] and increased PD-L1 expression on breast cancer cells after doxorubicin treatment [51]. Here, CD274 is linked to breast carcinoma.